STAT+: Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say
Eli Lilly has been featuring a telehealth company called Counsel Health on a list of providers for patients seeking a GLP-1 prescription.
Key points
- Continue to STAT+ to read the full story….
- With a new deal announced this week, one of those relationships is expected to grow more complicated.
On Tuesday, Counsel said it would be acquired by the smart ring maker Oura, allowing Counsel clinicians access to the data gathered through the ring so they can help customers understand the data and then diagnose or treat any conditions.
Pharma companies that make GLP-1 drugs have increasingly promoted telehealth companies that prescribe the popular treatments.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.